Norestal

Medicinal product

(Invented) name

Norestal

Active substance (s)

Escitalopramas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06AB10, Escitalopram

Marketing authorisation holder

Norameda, UAB, Lietuva

Date of authorisation

2009-12-17

Date of renewal

2015-10-16

Documents

1798_3-4 7-8 Norestal_perreg1016.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Escitalopramas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
30814	5514	1005514	lizdinė plokštelė	N28		Receptinis	LT/1/09/1798/007	Netiekiama	-	-	No	-	-	Download
38451	52128	1052128	lizdinė plokštelė	N56		Receptinis	LT/1/09/1798/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-04-05	Išregistruotas
2015-10-16	Perregistruotas
2009-12-17	Registruotas